Navigation Links


Transdermal at Biology News

FDA Clears the Way for Generic Versions of Transdermal Patches to Treat Chronic Pain

The Food and Drug Administration (FDA) has granted approval to Mylan Technologies, Inc., for the first generic version of Alza Corporation's Duragesic Patch (Fentanyl Transdermal System) used to treat patients suffering from severe chronic pain that cannot be managed with alternative analgesics. When applied to the skin, this patch technology delivers fentanyl, an opioid pain medication that is s...
Transdermal at Biology Products
Transdermal at Biology Technology
Transdermal at Medicine News

Transdermal HRT not cardioprotective in postmenopausal women with CAD

Transdermal hormone replacement therapy (HRT) does not reduce the risk of cardiac events in postmenopausal women with existing coronary artery disease (CAD). In the PHASE trial (Papworth HRT Atherosclerosis Study), researchers randomized 255 postmenopausal women with angiographically proven coronary artery disease to receive either transdermal HRT--17-beta-estradiol with or without cy...

Transdermal HRT not cardioprotective in postmenopausal women with Coronary Artery Disease

Transdermal hormone replacement therapy (HRT) does not reduce the risk of cardiac events in postmenopausal women with existing coronary artery disease (CAD). In the PHASE trial (Papworth HRT Atherosclerosis Study), researchers randomized 255 postmenopausal women with angiographically proven coronary artery disease to receive either transdermal HRT--17-beta-estradiol with or without cy...

Transdermal Vaccine Effective in Treating Alzheimer's Disease in Mice

University of South Florida researchers report that a novel needle-free vaccine approach// is effective and safe in clearing brain-damaging plaques from a mouse model of Alzheimer’s disease. The transdermal, or across the skin, vaccination, may offer a simpler way of preventing or treating the devastating neurodegenerative disease with less likelihood of adverse immune reactions. <br...
Transdermal at Medicine Products
Transdermal at Medicine Technology

TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment

LOD, Israel--(BUSINESS WIRE)--Jul 9, 2007 - TransPharma MedicalLtd., a specialty pharmaceutical company focused on the developmentand commercialization of drug products utilizing a proprietaryactive transdermal drug delivery technology, announced todaypromising results of its phase I clinical trials demonstrating thesafety and pharmacokinetic profile of its ViaDerm-hPTH (1-34)product for th...

NuPathe Reports Positive Phase One Results for NP101 Transdermal Therapy for Acute Migraine

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Jun 8, 2007 - NuPathe Inc., aprivately held specialty pharmaceutical company, today announcedpositive results from an initial Phase I study of NP101SmartRelief, a novel treatment for acute migraine being developedby NuPathe. NP101 combines NuPathe's SmartRelief(TM) proprietaryiontophoretic transdermal technology with sumatriptan, the mostwidely prescri...

Daytrana (methylphenidate transdermal system) Provides Significant Effectiveness in ADHD Symptom Relief in Both Boys and Girls

SAN DIEGO, May 23, 2007 /PRNewswire-FirstCall/ -- Shire plcannounced today that DAYTRANA(TM) (methylphenidate transdermalsystem), its Attention Deficit Hyperactivity Disorder (ADHD) patch,had significant efficacy in reducing the symptoms of ADHD in bothmale and female children aged 6 to 12 years, according to clinicaltrial results reported at the American Psychiatric Association(APA) ann...

12-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA (methylphenidate transdermal system)

SAN DIEGO, May 23, 2007 /PRNewswire-FirstCall/ -- Shire plcannounced that DAYTRANA(TM) (methylphenidate transdermal system),the first and only non-oral medication approved for treatment ofAttention Deficit Hyperactivity Disorder (ADHD) in children aged 6to 12 years, provided significant improvement in symptom controland tolerability, according to results of a 12-month open-labelstudy pre...

Phosphagenics to Commence Phase 1b Transdermal Insulin Clinical Trial in Second Quarter

MELBOURNE, Australia, May 03, 2007 /PRNewswire-FirstCall/ --Phosphagenics Limited (AIM: PSG) announced today that the Companyintends to initiate a Phase 1b clinical trial to demonstrate theefficacy and safety of the improved formulation of its transdermalinsulin product, TPM-02/Insulin, containing long-acting insulin.The trial is expected to commence in the second quarter of2007....
Other TagsArtArtArtArtArtArtArtArtIBMupondependdependdependtubetubetubetubetubetubetube
(Date:8/21/2008)... IL, Aug. 21 /PRNewswire-FirstCall/ - SXC Health S...SXCI , TSX: SXC), a leading provider of,pharmacy b...hierer,President and CEO, and Jeff Park, CFO, wil...hcare Conference at the Four Seasons Hotel in Bost...ace on Wednesday, September,3, 2008 at 2:40 pm ET....
(Date:8/21/2008)... Flu Vaccination Awareness Campaign...Electing a President is Not the Only Important Cho...aithersburg, MD (PRWEB) August 21, 2008 -- A new s...at vaccination ranks next to last among things the...influenza virus. Although public health guidelines...
(Date:8/21/2008)...ous Coalition for Reproductive Choice at the Democ...RNewswire-USNewswire/ -- RCRC -- the Religious,Coa...ents at the Democratic,National Convention to high...s in the campaign. RCRC,s president, The Reverend ...d is also available for media,interviews. RCRC is ...
(Date:8/21/2008)...IA BEACH, Va., Aug. 21, 2008 /PRNewswire/ -- The A...p. Sylvester Turner of Houston has,been honored wi...is part of the AMERIGROUP Foundation,s national pr...rts by government and community,leaders in improvi...t our,nation., "Our goal is to work together with...
Breaking Medicine News(10 mins):Health News:Survey Shows Parents' Best Intentions Out of Step With Expert Recommendations in Protecting Kids From Flu 2Health News:Survey Shows Parents' Best Intentions Out of Step With Expert Recommendations in Protecting Kids From Flu 3Health News:Survey Shows Parents' Best Intentions Out of Step With Expert Recommendations in Protecting Kids From Flu 4Health News:Survey Shows Parents' Best Intentions Out of Step With Expert Recommendations in Protecting Kids From Flu 5Health News:Texas State Rep. Sylvester Turner Honored as 'Champion for Children' by The AMERIGROUP Foundation 2
(Date:8/21/2008)...se can be irritating and possibly harmful for ever... whales in the Gulf of Mexico. , In recent yea... be a cause of stress for dolphins, whales and oth...study show that noise pollution especially noise ...ploration for oil and gas seems to have minimal e...
(Date:8/21/2008)...ze two meters of double-stranded DNA into the spac...smaller than the volume of genetic material it con...robe into a shoebox," said Riccardo Levi-Setti, Pr...hicago. , Now research into single-celled, aquat...ese and related organisms may have evolved more th...
(Date:8/21/2008)... be in Liverpool from 6-11 September, bringing ove...discuss the latest developments in science with th...University of Liverpool, there will be a host of e...Capital of Culture celebrations. , Each year, th...the UK and beyond. , Here is just a taster of w...
(Date:8/21/2008)...pse after renewed drug administration are typical ...s at the connection points in the brain,s reward c...ing was published by a research team from the Inst...n Cancer Research Center (DKFZ) in Heidelberg and ...st issue of Neuron . The results provide research...
Breaking Biology News(10 mins):Unique study shows oil, gas seismic work not affecting Gulf sperm whales 2Unique study shows oil, gas seismic work not affecting Gulf sperm whales 3Exploding chromosomes fuel research about evolution of genetic storage 2Exploding chromosomes fuel research about evolution of genetic storage 3Forward planning release from the BA 2Cocaine: How addiction develops 2AMDL Announces Guidance for FY2008 22502 1AMDL Announces Guidance for FY2008 22502 2AMDL Announces Guidance for FY2008 22502 3AMDL Announces Guidance for FY2008 22502 4AMDL Announces Guidance for FY2008 22502 5Lockheed Martin Wins 2424 Million IT Contract With CDC 22499 1Lockheed Martin Wins 2424 Million IT Contract With CDC 22499 2AST Awards Richard N Fine M D 2008 Ernest Hodge Distinguished Achievement Award 22495 1AST Awards Richard N Fine M D 2008 Ernest Hodge Distinguished Achievement Award 22495 2Barrier Therapeutics to Merge Into Stiefel Laboratories 6152 1Barrier Therapeutics to Merge Into Stiefel Laboratories 6152 2Barrier Therapeutics to Merge Into Stiefel Laboratories 6152 3Barrier Therapeutics to Merge Into Stiefel Laboratories 6152 4Barrier Therapeutics to Merge Into Stiefel Laboratories 6152 5
Other Contentshypocalcemiahypocalcemiahypodermichypodermichypoglycemiahypoglycemiahypoglycemiahypogonadismhypogonadism